calcium channel, voltage-dependent, gamma subunit 7 |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
TOPOTECAN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
MEGESTROL ACETATE |
Adenosine A2A |
-19% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 3 |
TICLOPIDINE |
Protein Serine/Threonine Kinase, ERK1 |
-19% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 3 |
TICLOPIDINE |
Protein Serine/Threonine Kinase, ERK1 |
-19% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
LANSOPRAZOLE |
Chemokine CCR5 |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3B |
4-METHYLPYRAZOLE |
Phosphodiesterase PDE3 |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3A |
4-METHYLPYRAZOLE |
Phosphodiesterase PDE3 |
-19% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, alpha |
TRANEXAMIC ACID |
Chemokine CXCR1(IL-8A) |
-19% |
NoneNone |
NoneNone |
View
|
androgen receptor |
TRIAMTERENE |
Testosterone |
-19% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 3 |
GANCICLOVIR |
Protein Serine/Threonine Kinase, ERK1 |
-19% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 3 |
GANCICLOVIR |
Protein Serine/Threonine Kinase, ERK1 |
-19% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 3 |
LANSOPRAZOLE |
Adrenergic beta3 |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
GEMCITABINE |
Serotonin 5-HT1A |
-19% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
GRISEOFULVIN |
Cyclooxygenase COX-2 |
-19% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
GRISEOFULVIN |
Cyclooxygenase COX-2 |
-19% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
VALPROIC ACID |
Chemokine CCR5 |
-19% |
NoneNone |
NoneNone |
View
|
bradykinin receptor, beta 2 |
VALPROIC ACID |
Bradykinin B2 |
-19% |
NoneNone |
NoneNone |
View
|
bradykinin receptor B2 |
VALPROIC ACID |
Bradykinin B2 |
-19% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, alpha |
BROMOCRIPTINE |
Chemokine CXCR1(IL-8A) |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
BROMOCRIPTINE |
Serotonin 5-HT3 |
-19% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
GOLD SODIUM THIOMALATE |
Cyclooxygenase COX-1 |
-19% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, alpha |
BLEOMYCIN A2 |
Chemokine CXCR1(IL-8A) |
-19% |
NoneNone |
NoneNone |
View
|
dopamine receptor D3 |
SULFANILAMIDE |
Dopamine D3 |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4A, cAMP specific |
ACONITINE |
Phosphodiesterase PDE4 |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4C, cAMP-specific |
ACONITINE |
Phosphodiesterase PDE4 |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4D |
ACONITINE |
Phosphodiesterase PDE4 |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 4B, cAMP specific |
ACONITINE |
Phosphodiesterase PDE4 |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
ACARBOSE |
Muscarinic M2 |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 5 |
ACARBOSE |
Muscarinic M5 |
-19% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
ACONITINE |
Vascular Endothelinal Growth Factor (VEGF) |
-19% |
NoneNone |
NoneNone |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
ACONITINE |
Vascular Endothelinal Growth Factor (VEGF) |
-19% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
CHLORTHALIDONE |
Neuropeptide Y2 |
-19% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
CHLORTHALIDONE |
Neuropeptide Y2 |
-19% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
ETHACRYNIC ACID |
Protein Tyrosine Kinase, Fyn |
-19% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, beta |
CLARITHROMYCIN |
Chemokine CXCR2 (IL-8B) |
-19% |
NoneNone |
NoneNone |
View
|
opioid receptor, delta 1 |
CLARITHROMYCIN |
Opiate delta |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
TRIMETHADIONE |
Glutamate, AMPA |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA2 |
TRIMETHADIONE |
Glutamate, AMPA |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
TRIMETHADIONE |
Glutamate, AMPA |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor subunit 4c |
TRIMETHADIONE |
Glutamate, AMPA |
-19% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
FLUCYTOSINE |
CYP450-1A2 Inhibition |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
BETAMETHASONE PHOSPHATE |
Serotonin 5-HT4 |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
BETAMETHASONE PHOSPHATE |
Serotonin 5-HT4 |
-19% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, beta |
TRIMETHADIONE |
Chemokine CXCR2 (IL-8B) |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3B |
BETAMETHASONE PHOSPHATE |
Phosphodiesterase PDE3 |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3A |
BETAMETHASONE PHOSPHATE |
Phosphodiesterase PDE3 |
-19% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
GALLAMINE TRIETHIODIDE |
CYP450-1A2 Inhibition |
-19% |
NoneNone |
NoneNone |
View
|
epidermal growth factor receptor |
NETILMICIN |
Protein Tyrosine Kinase, EGF Receptor |
-19% |
NoneNone |
NoneNone |
View
|
estrogen receptor 1 |
BISACODYL |
Estrogen ERalpha |
-19% |
NoneNone |
NoneNone |
View
|
estrogen receptor 1 |
BISACODYL |
Estrogen ERalpha |
-19% |
NoneNone |
NoneNone |
View
|
histamine receptor H 1 |
CILOSTAMIDE |
Histamine H1, Central |
-19% |
NoneNone |
NoneNone |
View
|
A3 adenosine receptor |
TRIAMCINOLONE ACETONIDE |
Adenosine A3 |
-19% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
ERYTHROMYCIN |
Cyclooxygenase COX-1 |
-19% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
ERYTHROMYCIN |
Cyclooxygenase COX-1 |
-19% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
DICYCLOMINE |
Cyclooxygenase COX-2 |
-19% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
DICYCLOMINE |
Cyclooxygenase COX-2 |
-19% |
NoneNone |
NoneNone |
View
|
cysteinyl leukotriene receptor 1 |
CITRININ |
Leukotriene D4 |
-19% |
NoneNone |
NoneNone |
View
|
cysteinyl leukotriene receptor 1 |
CITRININ |
Leukotriene D4 |
-19% |
NoneNone |
NoneNone |
View
|
bradykinin receptor, beta 2 |
DICYCLOMINE |
Bradykinin B2 |
-19% |
NoneNone |
NoneNone |
View
|
bradykinin receptor B2 |
DICYCLOMINE |
Bradykinin B2 |
-19% |
NoneNone |
NoneNone |
View
|
platelet-activating factor receptor |
DIFLUNISAL |
Platelet Activating Factor (PAF) |
-19% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 3 |
ATORVASTATIN |
Glycine, Strychnine-Sensitive |
-19% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 1 subunit |
ATORVASTATIN |
Glycine, Strychnine-Sensitive |
-19% |
NoneNone |
NoneNone |
View
|
glycine receptor, beta subunit |
ATORVASTATIN |
Glycine, Strychnine-Sensitive |
-19% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 2 subunit |
ATORVASTATIN |
Glycine, Strychnine-Sensitive |
-19% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, alpha polypeptide |
CLOMIPRAMINE |
Platelet-Derived Growth Factor (PDGF) |
-19% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, alpha polypeptide |
CLOMIPRAMINE |
Platelet-Derived Growth Factor (PDGF) |
-19% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, beta polypeptide |
CLOMIPRAMINE |
Platelet-Derived Growth Factor (PDGF) |
-19% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, beta polypeptide |
CLOMIPRAMINE |
Platelet-Derived Growth Factor (PDGF) |
-19% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
ALENDRONIC ACID |
CYP450-2C19 Inhibition |
-19% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
CLOZAPINE |
CYP450-2C9 Inhibition |
-19% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
CLOZAPINE |
CYP450-2C9 Inhibition |
-19% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
BENAZEPRIL |
Cyclooxygenase COX-2 |
-19% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
BENAZEPRIL |
Cyclooxygenase COX-2 |
-19% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
GABAPENTIN |
Protein Serine/Threonine Kinase, ERK2 |
-19% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
GABAPENTIN |
Protein Serine/Threonine Kinase, ERK2 |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 1 |
BENZBROMARONE |
Muscarinic M1 |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 3 |
BENZBROMARONE |
Muscarinic M3 |
-19% |
NoneNone |
NoneNone |
View
|
matrix metallopeptidase 9 |
GALLAMINE TRIETHIODIDE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-19% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
GALLAMINE TRIETHIODIDE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
CORTISONE ACETATE |
Glutamate, NMDA, Agonism |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
CORTISONE ACETATE |
Glutamate, NMDA, Agonism |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
CORTISONE ACETATE |
Glutamate, NMDA, Agonism |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
CORTISONE ACETATE |
Glutamate, NMDA, Agonism |
-19% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
BETA-ESTRADIOL 3-BENZOATE |
Chemokine CCR5 |
-19% |
NoneNone |
NoneNone |
View
|
nuclear receptor subfamily 3, group C, member 1 |
AMIFOSTINE |
Glucocorticoid |
-19% |
NoneNone |
NoneNone |
View
|
androgen receptor |
PYROGALLOL |
Testosterone |
-19% |
NoneNone |
NoneNone |
View
|
nitric oxide synthase 2A (inducible, hepatocytes) |
PHENOTHIAZINE |
Nitric Oxide Synthase, Inducible (iNOS) |
-19% |
NoneNone |
NoneNone |
View
|
nitric oxide synthase 2, inducible |
PHENOTHIAZINE |
Nitric Oxide Synthase, Inducible (iNOS) |
-19% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
BETA-ESTRADIOL 3-BENZOATE |
beta-Lactamase |
-19% |
NoneNone |
NoneNone |
View
|
melanocortin 4 receptor |
PHENOTHIAZINE |
Melanocortin MC4 |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
CELECOXIB |
Serotonin 5-HT2C |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
CELECOXIB |
GABAA, Benzodiazepine, Central |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
CELECOXIB |
GABAA, Benzodiazepine, Central |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, pi |
CELECOXIB |
GABAA, Benzodiazepine, Central |
-19% |
NoneNone |
NoneNone |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
CELECOXIB |
GABAA, Benzodiazepine, Central |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
CELECOXIB |
GABAA, Benzodiazepine, Central |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
CELECOXIB |
GABAA, Benzodiazepine, Central |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
CELECOXIB |
GABAA, Benzodiazepine, Central |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
CELECOXIB |
GABAA, Benzodiazepine, Central |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
CELECOXIB |
GABAA, Benzodiazepine, Central |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
CELECOXIB |
GABAA, Benzodiazepine, Central |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
CELECOXIB |
GABAA, Benzodiazepine, Central |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
CELECOXIB |
GABAA, Benzodiazepine, Central |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
CELECOXIB |
GABAA, Benzodiazepine, Central |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
CELECOXIB |
GABAA, Benzodiazepine, Central |
-19% |
NoneNone |
NoneNone |
View
|
acetylcholinesterase (YT blood group) |
CYCLOSPORIN A |
Acetylcholinesterase |
-19% |
NoneNone |
NoneNone |
View
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
CYCLOSPORIN A |
Acetylcholinesterase |
-19% |
NoneNone |
NoneNone |
View
|
acetylcholinesterase |
CYCLOSPORIN A |
Acetylcholinesterase |
-19% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
INSULIN |
Potassium Channel [KATP] |
-19% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
INSULIN |
Potassium Channel [KATP] |
-19% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
INSULIN |
Potassium Channel [KATP] |
-19% |
NoneNone |
NoneNone |
View
|
calcitonin receptor |
RANITIDINE |
Calcitonin |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
CYCLOSPORIN A |
Serotonin 5-HT3 |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
CYCLOSPORIN A |
Serotonin 5-HT3 |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1B |
NALOXONAZINE |
Serotonin 5-HT1B |
-19% |
NoneNone |
NoneNone |
View
|
caspase 1 |
COBALT (II) CHLORIDE |
Protease, Caspase 1 |
-19% |
NoneNone |
NoneNone |
View
|
caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) |
COBALT (II) CHLORIDE |
Protease, Caspase 1 |
-19% |
NoneNone |
NoneNone |
View
|
caspase 3, apoptosis related cysteine protease |
COBALT (II) CHLORIDE |
Protease, Caspase 1 |
-19% |
NoneNone |
NoneNone |
View
|
caspase 2 |
COBALT (II) CHLORIDE |
Protease, Caspase 1 |
-19% |
NoneNone |
NoneNone |
View
|
caspase 7 |
COBALT (II) CHLORIDE |
Protease, Caspase 1 |
-19% |
NoneNone |
NoneNone |
View
|
caspase 6 |
COBALT (II) CHLORIDE |
Protease, Caspase 1 |
-19% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
CYCLOSPORIN A |
Adenosine A2A |
-19% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 4 |
BEZAFIBRATE |
Chemokine CCR4 |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
DEXAMETHASONE |
Serotonin 5-HT2A |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
PROGESTERONE |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
PROGESTERONE |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
PROGESTERONE |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
PROGESTERONE |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
PROGESTERONE |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
PROGESTERONE |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
PROGESTERONE |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
PROGESTERONE |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
PROGESTERONE |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
PROGESTERONE |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
PROGESTERONE |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
PROGESTERONE |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
PROGESTERONE |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
tachykinin receptor 2 |
BACITRACIN |
Tachykinin NK2 |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
TESTOSTERONE |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
TESTOSTERONE |
Cyclooxygenase COX-1 |
-19% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
TESTOSTERONE |
Cyclooxygenase COX-1 |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
SIMVASTATIN |
Calcium Channel Type L, Benzothiazepine |
-19% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
R(-)-IBUPROFEN |
Protein Tyrosine Kinase, Fyn |
-19% |
NoneNone |
NoneNone |
View
|